Market Cap 4.88M
Revenue (ttm) 0.00
Net Income (ttm) -16.44M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.22
Volume 6,365
Avg Vol 45,538
Day's Range N/A - N/A
Shares Out 3.13M
Stochastic %K 0%
Beta -0.03
Analysts Strong Sell
Price Target $9.00

Company Profile

Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, which is in pre-clinical studies for the treatmen...

Industry: Biotechnology
Sector: Healthcare
Phone: 972 2 674 3430
Fax: 972 2 643 0982
Address:
The Goldyne Savad Inst. of Gene Therapy, Hadassah Hebrew Univ Medical Ctr, Jerusalem, Israel
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 23 at 5:17 PM
$SLXN RSI: 32.05, MACD: -0.1616 Vol: 0.18, MA20: 1.72, MA50: 2.07 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
BullsGame
BullsGame Feb. 19 at 8:26 PM
$SLXN I remember one day, not too long ago, this bad boy went up to $22 in pre market. I felt really good in that brief moment.
1 · Reply
DeltaHunter
DeltaHunter Feb. 18 at 9:25 AM
$SLXN Clinical-stage biotech where single-asset concentration raises volatility.
0 · Reply
WallStWireAds
WallStWireAds Feb. 17 at 1:33 PM
$SLXN https://www.tipranks.com/news/newswire/silexion-therapeutics-is-developing-a-potential-holy-grail-play-in-precision-oncology-nasdaq-slxn
0 · Reply
SwingGabe
SwingGabe Feb. 17 at 9:03 AM
$SLXN Pre-revenue biotech; early-stage
0 · Reply
WallStWireAds
WallStWireAds Feb. 10 at 10:13 PM
0 · Reply
WallStWireAds
WallStWireAds Feb. 8 at 3:31 PM
$SLXN $VSTM $HALO $NVCT After Big Pharma Validated KRAS, an Under the Radar Microcap Is Approaching Human Trials in Pancreatic Cancer >> https://thefinanceherald.com/after-big-pharma-validated-kras-an-under-the-radar-microcap-is-approaching-human-trials-in-pancreatic-cancer/
0 · Reply
WallStWireAds
WallStWireAds Feb. 6 at 3:46 PM
$SLXN https://www.bioreview.com/this-tiny-biotech-stock-could-unlock-a-new-approach-to-pancreatic-cancer-treatment-nasdaq-slxn/
0 · Reply
BillionerOfKing
BillionerOfKing Jan. 30 at 1:16 PM
$SLXN Current Stock Price: $1.96
0 · Reply
EdgeUnknown
EdgeUnknown Jan. 25 at 8:55 PM
Next Week Playbook $AQST , $SKYE , $SLXN, $HCTI and $BCAB
1 · Reply
Latest News on SLXN
Silexion Therapeutics Announces 1-for-15 Reverse Share Split

Jul 16, 2025, 8:44 AM EDT - 7 months ago

Silexion Therapeutics Announces 1-for-15 Reverse Share Split


Silexion Therapeutics Announces 1-for-9 Reverse Share Split

Nov 22, 2024, 4:30 PM EST - 1 year ago

Silexion Therapeutics Announces 1-for-9 Reverse Share Split


OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 23 at 5:17 PM
$SLXN RSI: 32.05, MACD: -0.1616 Vol: 0.18, MA20: 1.72, MA50: 2.07 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
BullsGame
BullsGame Feb. 19 at 8:26 PM
$SLXN I remember one day, not too long ago, this bad boy went up to $22 in pre market. I felt really good in that brief moment.
1 · Reply
DeltaHunter
DeltaHunter Feb. 18 at 9:25 AM
$SLXN Clinical-stage biotech where single-asset concentration raises volatility.
0 · Reply
WallStWireAds
WallStWireAds Feb. 17 at 1:33 PM
$SLXN https://www.tipranks.com/news/newswire/silexion-therapeutics-is-developing-a-potential-holy-grail-play-in-precision-oncology-nasdaq-slxn
0 · Reply
SwingGabe
SwingGabe Feb. 17 at 9:03 AM
$SLXN Pre-revenue biotech; early-stage
0 · Reply
WallStWireAds
WallStWireAds Feb. 10 at 10:13 PM
0 · Reply
WallStWireAds
WallStWireAds Feb. 8 at 3:31 PM
$SLXN $VSTM $HALO $NVCT After Big Pharma Validated KRAS, an Under the Radar Microcap Is Approaching Human Trials in Pancreatic Cancer >> https://thefinanceherald.com/after-big-pharma-validated-kras-an-under-the-radar-microcap-is-approaching-human-trials-in-pancreatic-cancer/
0 · Reply
WallStWireAds
WallStWireAds Feb. 6 at 3:46 PM
$SLXN https://www.bioreview.com/this-tiny-biotech-stock-could-unlock-a-new-approach-to-pancreatic-cancer-treatment-nasdaq-slxn/
0 · Reply
BillionerOfKing
BillionerOfKing Jan. 30 at 1:16 PM
$SLXN Current Stock Price: $1.96
0 · Reply
EdgeUnknown
EdgeUnknown Jan. 25 at 8:55 PM
Next Week Playbook $AQST , $SKYE , $SLXN, $HCTI and $BCAB
1 · Reply
Sookie1962
Sookie1962 Jan. 22 at 3:05 AM
0 · Reply
WallStWireAds
WallStWireAds Jan. 21 at 1:32 PM
$SLXN https://caplynx.io/6hcF0yO
1 · Reply
King68
King68 Jan. 15 at 11:17 PM
$SLXN i saw that i hope your right
0 · Reply
2pumps1dump
2pumps1dump Jan. 15 at 7:51 PM
$SLXN shake out, may have news soon. 🧐
0 · Reply
WallStWireAds
WallStWireAds Jan. 13 at 3:16 PM
$SLXN https://alphacatalyst.beehiiv.com/p/this-microcap-biotech-is-entering-human-trials-with-a-new-approach-to-cancer-s-undruggable-target-na
0 · Reply
Sookie1962
Sookie1962 Jan. 8 at 6:28 PM
0 · Reply
Sookie1962
Sookie1962 Jan. 8 at 6:27 PM
0 · Reply
DARKP00L
DARKP00L Jan. 6 at 12:50 PM
$SLXN 07:36 on Jan. 06 2026 Silexion Targets Human Trials in 2026 After Strong Progress Against KRAS Cancers #tradeideas
0 · Reply
WallStWireAds
WallStWireAds Jan. 6 at 12:31 PM
$SLXN https://caplynx.io/9neSc62
0 · Reply
Sookie1962
Sookie1962 Jan. 3 at 7:22 PM
$SLXN i have Question it seem like someone is again buying alot like really alot of warrants of SLXNW i wonder is there something going here???!!
0 · Reply
2pumps1dump
2pumps1dump Dec. 31 at 11:24 AM
$SLXN why the drop? 🧐
1 · Reply
Sam_hs
Sam_hs Dec. 30 at 4:53 PM
$SLXN I need translation for the 2 comments below me lol
1 · Reply